We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+472.96%
AUM
$718B
AUM Growth
-$112B
Cap. Flow
+$11.7B
Cap. Flow %
1.63%
Top 10 Hldgs %
17.54%
Holding
7,270
New
568
Increased
2,561
Reduced
2,729
Closed
610

Sector Composition

Rank Sector Weight
1 Technology 15.03%
2 Healthcare 12.52%
3 Financials 10.5%
4 Consumer Discretionary 7.88%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFNW
6701
DELISTED
First Financial Northwest, Inc
FFNW
$0 ﹤0.01%
10
ENZ
6702
DELISTED
Enzo Biochem, Inc.
ENZ
$0 ﹤0.01%
70
VOXX
6703
DELISTED
VOXX International Corporation Class A
VOXX
-13,760
Closed -$137K
ALTR
6704
CALL
DELISTED
Altair Engineering Inc
ALTR
-27,700
Closed -$1.78M
ATXI
6705
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
0
VMCAU
6706
DELISTED
Valuence Merger Corp. I Unit
VMCAU
-10,000
Closed -$100K
RVNC
6707
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
-4,600
Closed -$90K
AE
6708
DELISTED
Adams Resources & Energy Inc
AE
$0 ﹤0.01%
12
-118
-91% -$4.25K
BMTX
6709
DELISTED
BM Technologies, Inc.
BMTX
-56,283
Closed -$481K
VINC
6710
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
-385
Closed -$31K
GATO
6711
DELISTED
Gatos Silver, Inc.
GATO
-21,935
Closed -$95K
ASAI
6712
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$0 ﹤0.01%
+27
New +$427
PIK
6713
DELISTED
Kidpik Corp. Common Stock
PIK
-214
Closed -$5K
IVCPU
6714
DELISTED
Swiftmerge Acquisition Corp. Unit
IVCPU
-13,400
Closed -$133K
PFTA
6715
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
-50,000
Closed -$491K
LEV
6716
PUT
DELISTED
The Lion Electric Company
LEV
-300
Closed -$3K
ITI
6717
DELISTED
Iteris, Inc.
ITI
-20,091
Closed -$60K
GRDI
6718
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
-1,140
Closed -$11K
ORGS
6719
DELISTED
Orgenesis Inc. Common Stock
ORGS
$0 ﹤0.01%
10
SEEL
6720
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-12
Closed -$31.3K
TELL
6721
CALL
DELISTED
Tellurian Inc.
TELL
-267,600
Closed -$1.42M
AAMC
6722
DELISTED
Altisource Asset Management Corp
AAMC
-204
Closed -$2K
BIG
6723
CALL
DELISTED
Big Lots, Inc.
BIG
-750,000
Closed -$25.9M
IRAA
6724
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
-50,000
Closed -$489K
TLIS
6725
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
-463
Closed -$10K

Similar funds

JP Morgan Chase's Q2 2022 Portfolio in Review

As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
  • JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
  • JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
  • JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
  • JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.